glp-1 drugs and addiction Weight-Loss Could Address a Range of Addictions Hype Or Hope? Latest Research

AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

the MHRA has warned about falsified semaglutide products from unregulated sources

Pregnant women should avoid GLP-1 receptor agonists

Mitigating the Risk of Heart Disease People who have diabetes have twice the risk of heart disease

SeekPeptides members access detailed medication guides, protocol comparisons, and expert-reviewed resources that help navigate these complex treatment landscapes with confidence

Notably, in high-quality large RCTs, tirzepatide demonstrated greater effectiveness than GLP-1R mono agonists in reducing serum glucose, fat mass, and body weight